Dengue serotype 2 attenuated strain

Details for Australian Patent Application No. 2006257621 (hide)

Owner Centers for Disease Control and Prevention Sanofi Pasteur

Inventors Lang, Jean; Guy, Bruno; Huang, Claire; Kinney, Richard; Barban, Veronique

Agent Davies Collison Cave

Pub. Number AU-B-2006257621

PCT Pub. Number WO2006/134443

Priority 60/691,274 17.06.05 US

Filing date 7 June 2006

Wipo publication date 21 December 2006

Acceptance publication date 11 August 2011

International Classifications

C12N 7/08 (2006.01) Viruses, e.g. bacteriophages

A61K 39/12 (2006.01) Medicinal preparations containing antigens or antibodies - Viral antigens

C07K 14/18 (2006.01) Peptides having more than 20 amino acids

C12N 15/40 (2006.01) Mutation or genetic engineering - Proteins from RNA viruses, e.g. flaviviruses

Event Publications

31 January 2008 PCT application entered the National Phase

  PCT publication WO2006/134443 Priority application(s): WO2006/134443

11 August 2011 Application Accepted

  Published as AU-B-2006257621

8 December 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006257622-System and method for re-locating an object in a sample on a slide with a microscope imaging device

2006257610-Dengue serotype 1 attenuated strain